Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure
Journal of the American Heart Association · 05.08.2025 · 14 (15)
DOI: 10.1161/jaha.125.041401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 05.08.2025. Verfasst von Xiumeng Hua und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen State Key Laboratory of Cardiovascular Disease Fuwai Hospital Chinese Academy of Medical Sciences Shenzhen China. Hauptthemen laut MEDLINE: Heart Failure, Myocytes, Cardiac, Cardiomyopathy, Hypertrophic, Pyruvate Dehydrogenase Acetyl-Transferring Kinase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Hypertrophic cardiomyopathy (HCM), characterized by ventricular hypertrophy and fibrosis, frequently progresses to heart failure. Although metabolic dysregulation is implicated in HCM pathophysiology, the role of PDK4 (pyruvate dehydrogenase kinase 4), a key regulator of cardiac glucose and fatty acid oxidation, in HCM‐related heart failure remains unknown.
Methods
Single‐nucleus RNA sequencing was performed to analyze gene expression in patients with HCM (n=12), categorized into the following groups: normal, reduced, and heart failure. We validated our findings in additional cohorts of patients undergoing septal resection or heart transplantation. Cardiac‐specific Pdk4 knockout mice were crossed with Mybpc3 knockout mice, and PDK4 inhibition was also tested in Mybpc3 knockout mice. Cardiac metabolism was assessed via metabolic flux and Seahorse analysis in vivo and in vitro.
Results
Single‐nucleus RNA sequencing identified distinct cardiomyocyte clusters, with cardiomyocyte cluster 4 ( PDK4 + cardiomyocytes) significantly associated with impaired cardiac function and highly expressed in the cardiac tissue of patients with HCM heart failure. Elevated PDK4 inhibited pyruvate conversion to acetyl‐coenzyme A, impairing tricarboxylic acid cycle flux and reducing glucose oxidation, as confirmed by metabolic tracking. Both genetic ablation and pharmacological inhibition of PDK4 attenuated heart failure symptoms in Mybpc3 knockout mice.
Conclusions
Our findings highlight metabolic disturbance, specifically PDK4‐driven suppression of glucose oxidation, as crucial in HCM progression to heart failure. PDK4 represents a promising therapeutic target for preventing or treating heart failure in patients with HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen State Key Laboratory of Cardiovascular Disease Fuwai Hospital Chinese Academy of Medical Sciences Shenzhen China.
- Beijing Key Laboratory of Preclinical Research and Evaluation for Cardiovascular Implant Materials, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medica…
- Department of Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
- Department of Cardiac Surgery, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences Affiliated Cardiovascular Hospital of Kunming Medical University Kunming China.
ORCID-Profile: Xiumeng Hua, Zhe Sun, Congrui Wang, Hao Cui, Zeyu Cui, Mengni Bao, Han Mo, Jiangping Song
Zitieren
APA
Hua, X., Sun, Z., Wang, C., Cui, H., Shan, D., Tao, M., Cui, Z., Chang, Y., Bao, M., Mo, H., Chen, X., & Song, J. (2025). Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.041401
Vancouver
Hua X, Sun Z, Wang C, Cui H, Shan D, Tao M, et al. Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.041401
BibTeX
@article{Hua2025,
author = {Hua, Xiumeng and Sun, Zhe and Wang, Congrui and Cui, Hao and Shan, Dan and Tao, Menghao and Cui, Zeyu and Chang, Yuan and Bao, Mengni and Mo, Han and Chen, Xiao and Song, Jiangping},
title = {Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.041401}
}
EUVIMED